Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PALO ALTO, Calif., Oct. 11, 2023 /PRNewswire/ -- Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high...
On Tuesday, 647 companies set new 52-week lows.
Friday's session saw 112 companies set new 52-week lows.
Shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have earned a consensus rating of “Reduce” from the seven analysts that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company. The average 1 year target price […]
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...